Antifungal drug resistance among Candida species: mechanisms and clinical impact.
about
Bridging the Gap to Non-toxic Fungal Control: Lupinus-Derived Blad-Containing Oligomer as a Novel Candidate to Combat Human Pathogenic Fungi.Identification of new anti-Candida compounds by ligand-based pharmacophore virtual screening.Identification of Ebsulfur Analogues with Broad-Spectrum Antifungal ActivityRepurposing Approach Identifies Auranofin with Broad Spectrum Antifungal Activity That Targets Mia40-Erv1 PathwayPopulation structure and molecular genetic characterization of 5-flucytosine-susceptible and -resistant clinical Candida dubliniensis isolates from Kuwait.Ag(I) camphorimine complexes with antimicrobial activity towards clinically important bacteria and species of the Candida genus.Sensitization of Candida albicans to terbinafine by berberine and berberrubine.Antifungal Activity of Lactic Acid Bacteria Strains Isolated from Natural Honey against Pathogenic Candida SpeciesRetrospective observation of drug susceptibility of Candida strains in the years 1999, 2004, and 2015.Bibliometric analysis of literature on antifungal triazole resistance: 1980 - 2015.Dynamics of Mixed- Candida Species Biofilms in Response to Antifungals.Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.Fungicide Xylaria sp. BCC 1067 extract induces reactive oxygen species and activates multidrug resistance system in Saccharomyces cerevisiae.Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.Mass spectrometry applications in microbiology beyond microbe identification: progress and potential.Propolis: a potential natural product to fight Candida species infections.Diagnostic of Fungal Infections Related to Biofilms.Calcineurin in fungal virulence and drug resistance: Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach.Antimicrobial activity and mechanism of action of a thionin-like peptide from Capsicum annuum fruits and combinatorial treatment with fluconazole against Fusarium solani.(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study.Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentation.The Role of In Vitro Susceptibility Testing in the Management of Candida and Aspergillus.Candidiasis and the impact of flow cytometry on antifungal drug discovery.Antifungal Potential of Copper(II), Manganese(II) and Silver(I) 1,10-Phenanthroline Chelates Against Multidrug-Resistant Fungal Species Forming the Candida haemulonii Complex: Impact on the Planktonic and Biofilm Lifestyles.A newly identified amino acid substitution T123I in the 14α-demethylase (Erg11p) of Candida albicans confers azole resistance.Balancing iron and calcium: Flavin carrier family proteins in Aspergillus fumigatus virulence.Antifungal activity of a β-peptide in synthetic urine media: Toward materials-based approaches to reducing catheter-associated urinary tract fungal infections.Antifungal Susceptibility Testing of Ascomycetous Yeasts Isolated from AnimalsPhosphomannosylation and the Functional Analysis of the Extended Candida albicans MNN4-Like Gene Family.New Application of Neomycin B-Bisbenzimidazole Hybrids as Antifungal Agents.Liposomal and Deoxycholate Amphotericin B Formulations: Effectiveness against Biofilm Infections of Candida spp.Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil.Potent In Vitro Synergism of Fluconazole and Osthole against Fluconazole-Resistant Candida albicans.Nectar yeasts of the Metschnikowia clade are highly susceptible to azole antifungals widely used in medicine and agriculture.Transport Deficiency Is the Molecular Basis of Candida albicans Resistance to Antifungal Oligopeptides.Seven years of clinical experience with the Yeast Traffic Light PNA FISH: Assay performance and possible implications on antifungal therapy.Candida glabrata Biofilms: How Far Have We Come?MICAFUNGIN ENHANCES THE HUMAN MACROPHAGE RESPONSE TO Candida albicans THROUGH β-GLUCAN EXPOSURE.Yeast Biofilm as a Bridge Between Medical and Environmental Microbiology Across Different Detection Techniques.Antifungals susceptibility pattern of Candida spp. isolated from female genital tract at the Yaoundé Bethesda Hospital in Cameroon.
P2860
Q33843321-D9A2CC93-EA41-43C4-9BAD-751CC684DE7EQ35960473-F4B26ED0-083D-45DB-8CB7-9539E747C2F5Q36059265-340F0323-D2DF-474B-B6C1-3CDC6DDC0A08Q36266986-CC12A247-C003-4F45-9013-2E24D12B1E4EQ36336204-972681C3-E9B5-459C-8C55-8462926F765AQ36367084-55CE9B58-5D23-42B7-AC59-B2717F7728DCQ36741549-3C0D89CF-9C6D-433E-AA96-3C20B84570ECQ37619034-412A980F-F588-412E-B6B1-8368E99E3510Q37666788-D73333EB-72CB-4EBA-B832-95A4BA85132EQ37696920-40517E80-2616-4A40-AEA3-7E6184B008CBQ38603971-8D0E0334-DDC5-4FFA-B43E-1CB799210154Q38711698-EF5870D4-60C1-488D-B783-F1FE100370B5Q38737357-70AFDFA1-935F-4AFE-923C-C95830CE3C15Q38803537-D6A27E1B-5C0F-4E63-A336-4ABB8EFCEA0FQ38824041-24D855E9-ECF6-467F-AC34-DB1B735B2E8EQ38833403-43C43601-DCA1-4E88-924F-82C07B66B40FQ38853348-84A8305B-0E6C-4678-B3A9-DE64458C9388Q38871364-EACF1306-02B3-4881-88C6-F21FBBA97960Q39028891-2D5119EC-9E4E-4403-A545-E23FD8DE0137Q39812922-EA57F42D-3CD9-4F97-B54F-2A565830D045Q39844093-07747E9A-2E9C-45BF-8640-94C069B3B147Q40045635-26CEB6F4-C5E9-4E46-9FBA-248980B820FCQ40064579-381B6DC0-EB85-45CA-8F71-F5C0EE9DEDBCQ40119738-D1F8D5F4-62D4-443D-A93D-1CE2DF2BD809Q40277991-8CB02BCB-7BE6-491C-8805-C5DC8C4A6F1FQ40461325-FD43ADC6-40C9-48E0-8567-52673B9267CCQ40611787-563E4B7A-470A-4FDD-97E8-EFE09253065FQ40662963-0A0B28F1-B79A-46BB-BF3A-9F7C6D5F27EDQ45737164-D2A544C7-B014-40A8-9494-195AFDD1EA3EQ46244030-A2267E04-1FC2-4B51-B94B-BD9FFD96F0B9Q46250284-CF7AE897-1D28-4C98-B5F0-F32942E68A2CQ46302196-89EBAF8D-71F1-4268-851E-8CD8BAC0DDBBQ46352192-8BA0D0B9-F391-4555-99F5-1BCEC84EB825Q46619016-83F401D6-4C36-4AED-B394-4D17C5EC19ACQ47159764-ADAD37E6-1BB1-41B3-93AC-F874F69A6DB0Q47685703-A31A8DE4-0E86-445B-B55C-2939E03A78B4Q48163274-2085A57F-1FD5-430A-B812-CD8E0A11E8CEQ51747338-32820AAB-BEE5-4381-A1C7-7E055D3FE9B0Q52352055-5760E12E-FF6B-46DA-8C78-EB156929428CQ54997125-55DEF9BD-0546-4693-9A58-26C83A000FFE
P2860
Antifungal drug resistance among Candida species: mechanisms and clinical impact.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Antifungal drug resistance among Candida species: mechanisms and clinical impact.
@en
type
label
Antifungal drug resistance among Candida species: mechanisms and clinical impact.
@en
prefLabel
Antifungal drug resistance among Candida species: mechanisms and clinical impact.
@en
P2860
P50
P356
P1433
P1476
Antifungal drug resistance among Candida species: mechanisms and clinical impact.
@en
P2860
P356
10.1111/MYC.12330
P478
58 Suppl 2
P577
2015-06-01T00:00:00Z